Author Archives: Marta Figueiredo

COVID-19 Lockdown Led to Fewer Swiss Patients Adhering to Treatment With Little Impact on Disease Activity

A short interruption in in-person medical visits due to the COVID-19 pandemic significantly decreased treatment adherence but had little impact on disease activity in people with axial spondyloarthritis (axSpA), according to a real-life study in Switzerland. Notably, these parameters returned to pre-pandemic levels in the post-lockdown period. Similar trends…

RBP4 Protein Levels May Predict Responses to Humira in AS

Lower blood levels of retinol-binding protein 4 (RBP4) — a protein associated with inflammation, among other processes — in people with ankylosing spondylitis (AS) are associated with better treatment responses to Humira (adalimumab), a study shows. These findings suggest that RBP4 may be used as a biomarker to…